German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

A return to the stock exchange however remains the preference, one of the people said. Stada could be valued at around 10 to ...

Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...

FRANKFURT, March 18 (Reuters) - German pharmaceuticals company Stada has postponed a planned initial public offering (IPO) in Frankfurt because of market volatility, two people familiar with the ...

Verisure’s majority owner Hellman & Friedman has lined up more banks for a potential initial public offering of the security firm, as it steps up preparations for what could be one of Europe’s largest ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said. Bain Capital ...

FRANKFURT (Reuters) -German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the matter said, in a test for Europe's equity markets.

German pharmaceutical firm Stada is evaluating all ownership options, potentially considering an initial public offering. This decision follows reports of the company delaying its planned listing ...

Group sales increase by 9% to € 4.059 billion; adjusted cc EBITDA rises by 11% to € 886 million; adjusted cc EBITDA margin up to 21.8%; further sales and profits growth targeted in 2025 In Europe, ...